SeeburgPH, ShineJ, MartialJA, BaxterJD, GoodmanHM. 1977. Nucleotide sequence and amplification in bacteria of structural gene for rat growth hormone. Nature, 270:486–494.
2.
SeeburgPH, ShineJ, MartialJA, UllrichA, BaxterJD, GoodmanHM. 1977. Nucleotide sequence of part of the gene for human chorionic somatomammotropin: purification of DNA complementary to predominant mRNA species. Cell, 12:157–165.
3.
MartialJA, HallewellRA, BaxterJD, GoodmanHM. 1979. Human growth hormone: complementary DNA cloning and expression in bacteria. Science, 205:602–607.
4.
PerlmanD. 2011. John Baxter, UCSF cloner of growth hormone, dies. San Francisco Chronicle, October18.
5.
BaxterJD, BondyPK. 1966. Hypercalcemia of thyrotoxicosis. Ann Intern Med, 65:429–442.
6.
AprilettiJW, BaxterJD, LauKH, WestBL. 1995. Expression of the rat α1 thyroid hormone receptor ligand binding domain in Escherichia coli and the use of a ligand-induced conformational change as a method for its purification to homogeneity. Prot Express Purif, 6:363–370.
7.
WagnerRL, AprilettiJW, WestBL, BaxterJD, FletterickRJ. 1995. A structural role for hormone in the thyroid hormone receptor ligand binding domain. Nature, 378:690–697.
8.
FengWJ, RibeiroRCJ, WagnerRL, NguyenH, AprilettiJW, FletterickRJ, BaxterJD, KushnerPJ, WestBL. 1998. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science, 280:1747–1749.
9.
RibeiroRC, FengW, WagnerRL, CostaCH, PereiraAC, AprilettiJW, FletterickRJ, BaxterJD. 2001. Definition of the surface in the thyroid hormone receptor ligand binding domain for association as homodimers and heterodimers with retinoid X receptor. J Biol Chem, 276:14987–14995.
ScanlanTS. 2010. Sobetirome: a case history of bench-to-clinic drug discovery and development. Heart Fail Rev, 15:177–182.
12.
LadensonPW, KristensenJD, RidgwayEC, OlssonAG, CarlssonB, KleinI, BaxterJD, AngelinB. 2010. Treatment of dyslipidemia with the thyroid hormone analog eprotirome in statin-treated patients. New Engl J Med, 362:906–916.
